Biphenyl derivatives and their use in treating hepatitis C

Details Biphenyl derivatives and their use in treating hepatitis C Biphenyl derivatives and their use in treating hepatitis C

2011-08-30

2011-08-30

Habte, Kahsay T (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C544S359000, C544S383000, C514S252120

Reexamination Certificate

active

08008303

ABSTRACT:
Use of a compound which is a biphenyl derivative of formula (I), or a pharmaceutically acceptable salt thereof, for the treatment of Hepatitis Cwherein the variables are described herein.

REFERENCES:
patent: 5356893 (1994-10-01), Bradshaw et al.
patent: 6433236 (2002-08-01), Schiraldi et al.
patent: 2005/0020590 (2005-01-01), Lang et al.
patent: 2006/0004010 (2006-01-01), Habashita et al.
patent: 2007/0099938 (2007-05-01), Ohmoto et al.
patent: 0612524 (1998-08-01), None
patent: 1054005 (2000-11-01), None
patent: 1132376 (2001-09-01), None
patent: 1295867 (2003-03-01), None
patent: 91/03443 (1991-03-01), None
patent: 9501326 (1995-01-01), None
patent: 9630343 (1996-10-01), None
patent: 9736591 (1997-10-01), None
patent: 9917777 (1999-04-01), None
patent: 0042011 (2000-07-01), None
patent: 0119788 (2001-03-01), None
patent: 0121577 (2001-03-01), None
patent: 0164642 (2001-09-01), None
patent: 02089738 (2002-11-01), None
patent: 03006628 (2003-01-01), None
patent: 03/032970 (2003-04-01), None
patent: 03/032972 (2003-04-01), None
patent: 03/032980 (2003-04-01), None
patent: 03062392 (2003-07-01), None
patent: 03068747 (2003-08-01), None
patent: 2004041789 (2004-05-01), None
patent: 2004043335 (2004-05-01), None
patent: 2004083174 (2004-09-01), None
patent: 2004/089874 (2004-10-01), None
patent: 2004/089876 (2004-10-01), None
patent: 2004089296 (2004-10-01), None
patent: 2005009539 (2005-02-01), None
patent: 2005021721 (2005-03-01), None
patent: 2005023761 (2005-03-01), None
patent: 2005065361 (2005-07-01), None
patent: 2005086661 (2005-09-01), None
patent: 2006001958 (2006-01-01), None
patent: 2006014012 (2006-02-01), None
patent: 2006037335 (2006-04-01), None
patent: 2006047528 (2006-05-01), None
patent: 2006/083271 (2006-08-01), None
patent: 2006/091858 (2006-08-01), None
patent: 2006102760 (2006-10-01), None
patent: 2007009083 (2007-01-01), None
patent: 2007087441 (2007-08-01), None
patent: 2007088996 (2007-08-01), None
patent: 2007103162 (2007-09-01), None
patent: 2007138242 (2007-12-01), None
patent: 2008044667 (2008-04-01), None
patent: 2008046216 (2008-04-01), None
patent: 2008073670 (2008-06-01), None
patent: 2008092006 (2008-07-01), None
patent: 2008147864 (2008-12-01), None
patent: 2009034390 (2009-03-01), None
Ishida et al; Involvement of p38 signaling pathway in interferon-a-mediated antiviral activity toward hepatitis C virus; Biochemical and Biophysical Research Communications; 2004; 321; 722-727.
Carter; Diphenylcarboxamides As Inhibitors of HCV Non-structural Protein NS5A, presentation at 23rd ICAR (Apr. 26, 2010).
Carter et al; Diphenylcarboxamides As Inhibitors of HCV Non-structural Protein NS5A, poster at 23rd ICAR (Apr. 26, 2010).

Affiliated with

Also associated with

Rating

Biphenyl derivatives and their use in treating hepatitis C does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biphenyl derivatives and their use in treating hepatitis C, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biphenyl derivatives and their use in treating hepatitis C will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2707041